ERBB2 and breast cancer: Human epidermal growth factor receptor 2 (HER2), which belongs to the epidermal growth factor receptor (EGFR) family, plays a key role in human malignancies and is overexpressed in approximately 30% of human breast cancers [1] and in many other cancer types, including stomach, bladder, ovarian, and lung carcinomas [1–4].